Cargando…
An injectable CRISPR therapy instructs B cells to produce anti-HIV antibodies
Autor principal: | Collins, Logan Thrasher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692189/ https://www.ncbi.nlm.nih.gov/pubmed/36447676 http://dx.doi.org/10.1093/synbio/ysac027 |
Ejemplares similares
-
High-throughput antibody engineering in mammalian cells by CRISPR/Cas9-mediated homology-directed mutagenesis
por: Mason, Derek M, et al.
Publicado: (2018) -
Could a simple model of COVID-19 infections be the key to designing better virus-based therapies?
por: King, Connor R
Publicado: (2022) -
CRISPR–Cas12a system in fission yeast for multiplex genomic editing and CRISPR interference
por: Zhao, Yu, et al.
Publicado: (2020) -
Reprogramming the proteome for cell-free protein expression
por: Harimoto, Tetsuhiro
Publicado: (2020) -
Development of a ‘clickable’ non-natural nucleotide to visualize the replication of non-instructional DNA lesions
por: Motea, Edward A., et al.
Publicado: (2012)